Cargando…
Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
AIMS: The effectiveness of angiotensin‐converting enzyme inhibitors (ACE‐I) and angiotensin II receptor blockers (ARB) has not been demonstrated in patients with heart failure with preserved ejection fraction (HFpEF). We recently reported significant interaction between the use of ACE‐I and/or ARB (...
Autores principales: | Sunaga, Akihiro, Hikoso, Shungo, Tamaki, Shunsuke, Seo, Masahiro, Yano, Masamichi, Hayashi, Takaharu, Nakagawa, Akito, Nakagawa, Yusuke, Kurakami, Hiroyuki, Yamada, Tomomi, Kitamura, Tetsuhisa, Sato, Taiki, Oeun, Bolrathanak, Kida, Hirota, Sotomi, Yohei, Dohi, Tomoharu, Okada, Katsuki, Mizuno, Hiroya, Nakatani, Daisaku, Yamada, Takahisa, Yasumura, Yoshio, Sakata, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065837/ http://dx.doi.org/10.1002/ehf2.13873 |
Ejemplares similares
-
Change in Nutritional Status during Hospitalization and Prognosis in Patients with Heart Failure with Preserved Ejection Fraction
por: Sunaga, Akihiro, et al.
Publicado: (2022) -
Prognostic significance of dipstick proteinuria in heart failure with preserved ejection fraction: insight from the PURSUIT-HFpEF registry
por: Oeun, Bolrathanak, et al.
Publicado: (2021) -
Sex Differences in Heart Failure With Preserved Ejection Fraction
por: Sotomi, Yohei, et al.
Publicado: (2021) -
Minimal subphenotyping model for acute heart failure with preserved ejection fraction
por: Sotomi, Yohei, et al.
Publicado: (2022) -
P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials
por: Sotomi, Yohei, et al.
Publicado: (2023)